<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-11-15</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543700/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543700-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The addition of gastrojejunostomy and Braun&rsquo;s jejunojejunostomy in distal segmental duodenectomy can reduce the incidence of grade B-C DGE, potentially facilitating timely adjuvant imatinib therapy. Future multicenter studies are needed to confirm these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543701/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Late-onset drug-resistant epilepsy in pyridoxamine 5&#39;-phosphate oxidase deficiency: a case report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543701-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Physicians ought to be aware of manifestations of vitamin B6 deficiency such as mimicking tic and consider it in the differential for drug-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care concepts that are tailored to individual needs and the risk of recurrences, side effects and late effects are lacking in routine care in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543778/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Cardiac arrhythmias during and after thoracic irradiation for malignancies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543778-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Thoracic radiotherapy can be safely administered in patients with CIEDs. However, patients with a history of arrhythmia are more prone to arrhythmic events during and after radiation. These findings highlight the need for personalized arrhythmia management strategies and further research to understand the mechanisms underlying the antiarrhythmic effects of thoracic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543799/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Optical control of cardiac electrophysiology by the photochromic ligand azobupivacaine 2</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543799-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION AND IMPLICATIONS: The present study provides the first proof of concept that AB2 enables gradual control of cardiac electrophysiology by light. AB2 may hence open the door to the development of an optical defibrillator based on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543914/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Predictors for improvement in personality functioning during outpatient psychotherapy: A machine learning approach within a psychodynamic psychotherapy sample</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543914-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Overall, the improvement in personality functioning during psychotherapy is determined more by the sum of a large number of small effects than by individual variables. In particular, variables that capture social areas of life proved to be robust &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">The prognostic value of cystography-measured bladder capacity on very early continence rates after radical prostatectomy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The cystography-measured bladder capacity may be a good predictor of the recovery of post-prostatectomy urinary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544316/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Microvascular Reconstructions in Elderly Patients With Oral Squamous Cell Carcinoma - Too Old for Surgical Treatment?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544316-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Tumor surgery including neck dissection in combination with primary microvascular reconstruction is a safe therapy in patients of advanced age. This results in excellent oncological outcome with no significant disadvantages in terms of perioperative morbidity, hospitalization or flap &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544372/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Implementing a stabilizing intervention for traumatized refugees in temporary accommodations in South-West Germany - a randomized controlled pilot trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544372-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The prevalence of trauma-related disorders, such as post-traumatic stress disorder (PTSD), as well as depressive or anxiety disorders, are significantly increased in refugees compared to the general population. This is due to the high risk of burdening and potentially traumatic experiences before, during and after their flight. However, the treatment options for these mental illnesses are significantly limited due to the legal uncertainties surrounding the asylum procedure as well as &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Presolar Grains as Probes of Supernova Nucleosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We provide an overview of the isotopic signatures of presolar supernova grains, specifically focusing on ^(44)Ti-containing grains with robustly inferred supernova origins and their implications for nucleosynthesis and mixing mechanisms in supernovae. Recent technique advancements have enabled the differentiation between radiogenic (from ^(44)Ti decay) and nonradiogenic ^(44)Ca excesses in presolar grains, made possible by enhanced spatial resolution of Ca-Ti isotope analyses with the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544625/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Understanding the Risk Factors, Burden, and Interventions for Chronic Respiratory Diseases in Low- and Middle-Income Countries: A Scoping Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544625-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our research shows a strong link between air pollution, occupational and environmental exposures, and the prevalence of COPD and asthma in LMICs. It suggests that targeted interventions are effective ways to mitigate these diseases and also highlights the significant impact of climate change on respiratory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544885/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Sputum availability and quality in country-level TB prevalence surveys</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544885-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544941/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544941-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: We report the partial regression of metastatic squamous cell carcinoma (SCC) after reduction of long-term azathioprine therapy while awaiting surgery. The patient was a 69-year-old man with a history of kidney transplantation. Moderately differentiated SCC arising in the anterior neck was initially diagnosed, followed later by poorly differentiated SCC metastases to cervical lymph nodes. Lymph node clearance was performed 28 days after a reduction in azathioprine dosage. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20241115175759&amp;v=2.18.0.post9&#43;e462414">Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20241115175759-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Transplant recipients have an increased risk of complications, including graft dysfunction and infections, which can be life-threatening if not recognized early. Pneumonia ranks as one of the most frequent complications in both solid organ and hematopoietic stem cell transplants. Clinical symptoms manifest late during infections in immunocompromised patients. An aggressive approach centered on early confirmatory diagnosis and a low threshold for empiric therapy is often the most &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545335/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Desmoid tumors: Old and new drugs for a rare and challenging disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545335-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545345/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Long-TermÂ Single-Molecule Tracking in Living Cells Using Weak-Affinity Protein Labeling</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545345-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Single-particle tracking (SPT) has become a powerful tool to monitor the dynamics of membrane proteins in living cells. However, permanent labeling strategies for SPT suffer from photobleaching as a major limitation, restricting observation times, and obstructing the study of long-term cellular processes within single living cells. Here, we use exchangeable HaloTag Ligands (xHTLs) as an easy-to-apply labeling approach for live-cell SPT and demonstrate extended observation times of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Haematogenous seeding in mycosis fungoides and SÃ©zary syndrome: Current evidence and clinical implications</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of diseases characterised by abnormal neoplastic T-cell growth in the skin. Mycosis fungoides (MF), the most common CTCL, manifests as erythematous skin patches and/or plaques, tumours or erythroderma. The disease may involve blood, lymph nodes and rarely viscera. SÃ©zary syndrome (SS) is a unique leukaemia/lymphoma syndrome related to MF, which presents with blood and skin involvement at diagnosis. The pathogenesis of MF/SS is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545514/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Pain Remission Following Delayed Targeted Muscle Reinnervation in Amputees</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545514-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Targeted muscle reinnervation (TMR) has demonstrated efficacy for treatment of neuropathic pain. This study aims to identify patients for whom delayed TMR may be most effective and to identify associated factors for favorable pain outcomes in this patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545524/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Gliosarcoma: A Multi-Institutional Analysis on Clinical Outcomes and Prognostic Factors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545524-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Trimodal therapy comprising surgical resection, pRT and TMZ-based chemotherapy appears to have the most beneficial effect on survival in GSM patients. Smaller tumor size, younger age and methylated MGMT promoters are associated with improved survival. To our knowledge, this is the largest multi-institutional cohort study investigating outcomes and prognostic factors for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545723/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">T-shaped 14 Electron Rhodium Complexes: Potential Active Species in C-H Activation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545723-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Two T-shaped 14-electron rhodium complexes 2a and 2b, &ldquo;framed&rdquo; and thus stabilized by PNP pincer ligands have been synthesized. The bis(t-butyl)phosphine derived PNPtBu-rhodium 2a was isolated from pentane as the more stable cyclometalated Rh(III) hydrido complex and found to be in equilibrium with the T-shaped 14e-Rh(I) complex 2aT which itself could be directly crystallized upon change of the solvent. The cyclometallation is suppressed using an adamantyl substituted PNPAd ligand to give &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545955/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Fine-tuning stress responses by auxiliary feedback loops that sense damage repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545955-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mogk and den Brave discuss exciting results from a comprehensive screen of heat shock response components in yeast, published in this issue by Pincus and colleagues (<a href="https://doi.org/10.1083/jcb.202401082)">https://doi.org/10.1083/jcb.202401082)</a>. Their work reveals modulatory regulatory loops that fine-tune the timing of the shutdown of this highly conserved &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0nhu0WFh">Trumpä¸èƒ½ä¸ç»è¿‡å›½ä¼šå‚è®®é™¢ç›´æ¥ä»»å‘½å†…é˜æˆå‘˜ã€‚ä»–å¯ä»¥å¼ºåˆ¶å›½ä¼šrecessï¼ˆä¼‘ä¼šï¼‰ï¼Œç„¶åä»»å‘½å†…é˜ï¼Œä½†è¿™æ ·ä¸ä»…æ“ä½œéš¾åº¦å¤§ï¼Œä¸”ä¼šè¢«å‘Šä¸Šæ³•åº­ï¼Œæ›´é‡è¦çš„æ˜¯ï¼Œä»–åªèƒ½ä»»å‘½ä¸´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0nhu0wfh/">
    
    
    
    
    
      
    
    Trumpä¸èƒ½ä¸ç»è¿‡å›½ä¼šå‚è®®é™¢ç›´æ¥ä»»å‘½å†…é˜æˆå‘˜ã€‚ä»–å¯ä»¥å¼ºåˆ¶å›½ä¼šrecessï¼ˆä¼‘ä¼šï¼‰ï¼Œç„¶åä»»å‘½å†…é˜ï¼Œä½†è¿™æ ·ä¸ä»…æ“ä½œéš¾åº¦å¤§ï¼Œä¸”ä¼šè¢«å‘Šä¸Šæ³•åº­ï¼Œæ›´é‡è¦çš„æ˜¯ï¼Œä»–åªèƒ½ä»»å‘½ä¸´æ—¶å†…é˜æˆå‘˜ï¼Œä¸€æ—¦å›½ä¼šæ¢å¤ï¼Œé‚£ä¹ˆè¦é‡æ–°æ¢å¤ä»»å‘½è¿‡ç¨‹ã€‚å¦‚æœè¿˜è®°å¾—ä»–2017-2021å¹´ç¬¬ä¸€ä»»æ“ä½œï¼Œä»–æœ€ç»ˆé€‰æ‹©çš„æ–¹å¼æ˜¯actingï¼Œå°±æ˜¯å„ä¸ªéƒ¨å§”ï¼Œéƒ½æ˜¯ä»£ç†éƒ¨é•¿ã€‚ç¬¬äºŒæ˜¯ä»–æ—¢ä¸èƒ½åºŸé™¤åœ¨ç¾å›½å‡ºç”Ÿåè‡ªåŠ¨èµ‹äºˆçš„ç¾å›½å…¬æ°‘æƒï¼Œä¹Ÿä¸èƒ½ä»»ç¬¬ä¸‰æ¬¡æ€»ç»Ÿã€‚è®¸å¤šäººä¸ç†è§£ç¾å›½çš„ç«‹æ³•å’Œæ³•åº­åˆ¤å†³ã€‚å‡ºç”Ÿå…¬æ°‘æƒæ˜¯ç¾å›½å®ªæ³•ç¬¬14ä¿®æ­£æ¡ˆï¼Œä¸€ä¸ªäººæœ€å¤šåªèƒ½ä»»ä¸¤å±Šæ€»ç»Ÿï¼ˆä¸ç®¡è¿ç»­è¿˜æ˜¯ä¸è¿ç»­ï¼‰æ˜¯ç¾å›½å®ªæ³•ç¬¬22ä¿®æ­£æ¡ˆã€‚ç«‹æ³•éœ€è¦ä¼—è®®é™¢ç®€å•å¤šæ•°å’Œå‚è®®é™¢60%é€šè¿‡ã€‚ä½†æ˜¯ä¿®æ”¹ä¸Šè¿°å®ªæ³•ï¼Œéœ€è¦ä¼—è®®é™¢å’Œå‚è®®é™¢éƒ½2/3é€šè¿‡æ‰èƒ½è·å¾—æè®®ï¼ˆProposalï¼‰ï¼Œæœ€ç»ˆ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0onYxTCk">å¾ˆå¤šäººè¯´ç¾å›½å†…æ”¿æœ¬è´¨ä¸Šæ˜¯ä¸ªæ•°å­¦æ¸¸æˆï¼Œå› ä¸ºå†…æ”¿å…¶å®å°±æ˜¯åœ¨æ•°ç¥¨æ•°ã€‚å¯¹ç¾å›½å†…æ”¿çœŸæœ‰å…´è¶£çš„äººï¼Œä¼šçŸ¥é“ç¾å›½å†…æ”¿ä¸»è¦æ˜¯é€šè¿‡å›½ä¼šç«‹æ³•å®ç°çš„ï¼Œè€Œè”é‚¦æ³•é™¢ç³»ç»Ÿï¼ˆå°¤å…¶æ˜¯æœ€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0onyxtck/">
    
    
    
    
    
      
    
    å¾ˆå¤šäººè¯´ç¾å›½å†…æ”¿æœ¬è´¨ä¸Šæ˜¯ä¸ªæ•°å­¦æ¸¸æˆï¼Œå› ä¸ºå†…æ”¿å…¶å®å°±æ˜¯åœ¨æ•°ç¥¨æ•°ã€‚å¯¹ç¾å›½å†…æ”¿çœŸæœ‰å…´è¶£çš„äººï¼Œä¼šçŸ¥é“ç¾å›½å†…æ”¿ä¸»è¦æ˜¯é€šè¿‡å›½ä¼šç«‹æ³•å®ç°çš„ï¼Œè€Œè”é‚¦æ³•é™¢ç³»ç»Ÿï¼ˆå°¤å…¶æ˜¯æœ€é«˜æ³•ï¼‰æœ‰å¯¹å¾ˆå¤šæ”¿ç­–çš„é‡Šæ³•æƒï¼ˆè®¤åŒæˆ–å¦å†³ï¼‰ã€‚æ‰€ä»¥ç¾å›½å†…æ”¿å’Œç¨‹åºï¼Œå¾ˆå¤šéƒ½æ˜¯é€šè¿‡å›½ä¼šå’Œæ³•å®˜æŠ•ç¥¨å†³å®šçš„ï¼Œæ¯”å¦‚ä»»å‘½å†…é˜å’Œæ³•å®˜éœ€è¦å‚è®®é™¢51ç¥¨ï¼Œé€šè¿‡ç«‹æ³•å’Œè´¢æ”¿é¢„ç®—éœ€è¦ä¼—è®®é™¢ç®€å•å¤šæ•°å’Œå‚è®®é™¢60ç¥¨ä»¥ä¸Šï¼Œå¼¹åŠ¾æ€»ç»Ÿåˆ™éœ€è¦ä¼—è®®é™¢ç®€å•å¤šæ•°å’Œå‚è®®é™¢67ç¥¨ï¼Œä¿®å®ªåˆ™æ˜¯å¤©èŠ±æ¿æéš¾åº¦ã€‚æ³•åº­ä¹Ÿæ˜¯å¦‚æ­¤ï¼Œè”é‚¦ä¸Šè¯‰æ³•åº­ï¼ˆappeal courtï¼‰ä¸€èˆ¬3ä¸ªæ³•å®˜2ä¸ªå¤šæ•°å¯ä»¥åˆ¤å†³ï¼Œè€Œæœ€é«˜æ³•9ä¸ªæ³•å®˜ç®€å•å¤šæ•°ï¼ˆ5ä¸ªï¼‰å¯ä»¥åˆ¤å†³ã€‚ç”±æ­¤è¯´ç¾å›½å†…æ”¿æ˜¯ä¸ªæ•°å­¦æ¸¸æˆ - å°±çœ‹ä½ æœ‰æ²¡æœ‰è¶³å¤Ÿç¥¨æ•°ã€‚æ¯ä¸ªè®®å‘˜ä¸€èˆ¬éƒ½æœ‰è‡ªå·±çš„çº²é¢†ï¼ˆä¸ªäººç½‘ç«™ä¸Šä¸€èˆ¬éƒ½å¯ä»¥æ‰¾åˆ°ï¼‰å’ŒæŠ•ç¥¨çºªå½•ï¼Œå¯¹äºä¸€ä¸ªå…³é”® &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0phWvHgA">æ‹‰ä¸è£”æ˜¯2024å¹´å¤§é€‰æŠ•ç¥¨å˜åŒ–æœ€æ˜¾è‘—çš„ä¸€ä¸ªé€‰æ°‘ç¾¤ä½“ï¼Œè€Œä»–ä»¬æŠ•ç¥¨å˜åŒ–çš„åŸå› æ˜¯è¿‡å»ä¸€å‘¨å¾ˆå¤šåª’ä½“äº‰ç›¸æŠ¥é“çš„ç„¦ç‚¹ã€‚ä»Šå¤©538 podcastè¯·äº†Carlos Odioåšäº†ä¸€æœŸèŠ‚ç›®ï¼Œä¸“é—¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0phwvhga/">
    
    
    
    
    
      
    
    æ‹‰ä¸è£”æ˜¯2024å¹´å¤§é€‰æŠ•ç¥¨å˜åŒ–æœ€æ˜¾è‘—çš„ä¸€ä¸ªé€‰æ°‘ç¾¤ä½“ï¼Œè€Œä»–ä»¬æŠ•ç¥¨å˜åŒ–çš„åŸå› æ˜¯è¿‡å»ä¸€å‘¨å¾ˆå¤šåª’ä½“äº‰ç›¸æŠ¥é“çš„ç„¦ç‚¹ã€‚ä»Šå¤©538 podcastè¯·äº†Carlos Odioåšäº†ä¸€æœŸèŠ‚ç›®ï¼Œä¸“é—¨åˆ†æäº†è¿™æ¬¡æ˜¾è‘—å½±å“å¤§é€‰ç»“æœçš„æ‹‰ä¸è£”çš„æ°‘æ„å˜åŒ–ã€‚Odioä¸ä»…æ˜¯å…¨ç¾å›½æœ€å¥½çš„æ‹‰ä¸è£”æ°‘æ„ç ”ç©¶ä¸“å®¶å’Œpollsterï¼ˆæ°‘æ„è°ƒæŸ¥ä¸“å®¶ï¼‰ä¹‹ä¸€ï¼›ä»–æœ¬äººä½œä¸ºæ‹‰ä¸è£”ç”·æ€§ï¼Œååˆ†å…³å¿ƒå’Œç†è§£è‡ªå·±ç¤¾åŒºçš„æ°‘æ„å˜åŒ–ã€‚ä»–ä»Šå¤©è¯´çš„å‡ ç‚¹éå¸¸æœ‰å¯å‘æ€§ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å››å¹´å‰ï¼ŒOdioåœ¨538ä¸Šä»‹ç»äº†2020å¹´å¤§é€‰å‰æ‹‰ä¸è£”æ°‘æ„å˜åŒ–ï¼Œå®é™…ä¸Šåœ¨2020å¹´å¤§é€‰å‰ï¼Œæ‹‰ä¸è£”å°±å‘ç”Ÿäº†æ˜¾è‘—çš„å‘ç¾å›½ä¿å®ˆæ´¾çš„å˜è¿ï¼Œè€Œå…¶ä¸­å…³é”®åŸå› æ˜¯ä»–ä»¬è·å¾—ä¿¡æ¯çš„æ¥æºï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/P0oJTkZse">è¯´èµ·æ¥â€¦â€¦å¾®åšç©äº†è¿™ä¹ˆå¤šå¹´ï¼Œæˆ‘å¥½åƒä¸€æ¬¡å¥–éƒ½æ²¡ä¸­è¿‡ - è½¬å‘ @52TOYS:&amp;ensp;ç”±ä¸Šå½±å…ƒæ–‡åŒ–æ­£ç‰ˆæˆæƒï¼Œ52TOYSè”åä¸Šç¾å½±ä½œå“ã€Šå¤©ä¹¦å¥‡è°­ã€‹ï¼Œç”¨å¯åŠ¨ç©å…·å†ç°ç»å…¸ï¼[æ†§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-p0ojtkzse/">
    
    
    
    
    
      
    
    è¯´èµ·æ¥â€¦â€¦å¾®åšç©äº†è¿™ä¹ˆå¤šå¹´ï¼Œæˆ‘å¥½åƒä¸€æ¬¡å¥–éƒ½æ²¡ä¸­è¿‡<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@52TOYS<!-- raw HTML omitted -->:â€‚ç”±ä¸Šå½±å…ƒæ–‡åŒ–æ­£ç‰ˆæˆæƒï¼Œ52TOYSè”åä¸Šç¾å½±ä½œå“ã€Šå¤©ä¹¦å¥‡è°­ã€‹ï¼Œç”¨å¯åŠ¨ç©å…·å†ç°ç»å…¸ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å‘æ¡ã€æœºå…³ã€å…³èŠ‚å¯åŠ¨â€¦â€¦ä¸€å¥—ç›²ç›’å¤šé‡ç©æ³•ï¼è¯™è°æœ‰è¶£ï¼Œä¸€ç©ä¸€ä¸ªä¸Šç˜¾~<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/P0p8VDzaH">æ—©ä¸Šå‡ºé—¨å‰ï¼Œç”µè¯å“äº†ã€‚æˆ‘æ‰‹é‡Œæ­£å¿™ï¼Œå–Šé©¬å°çƒ¦å¸®å¿™å¼€å…æã€‚ä»–ä¸€å¼€ï¼Œé‚£è¾¹ä¼ æ¥äº²åˆ‡çš„é—®å€™ï¼šâ€œå®¶é•¿ä½ å¥½ï¼Œè¿™é‡Œæ˜¯æµ·æ·€åå¸ˆâ€¦â€¦â€ ä»–è¿˜æ²¡ç­‰æˆ‘å‘è¯ï¼Œâ€œå•ªâ€å°±ç»™æŒ‚äº†ï¼Œç„¶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-p0p8vdzah/">
    
    
    
    
    
      
    
    æ—©ä¸Šå‡ºé—¨å‰ï¼Œç”µè¯å“äº†ã€‚æˆ‘æ‰‹é‡Œæ­£å¿™ï¼Œå–Šé©¬å°çƒ¦å¸®å¿™å¼€å…æã€‚ä»–ä¸€å¼€ï¼Œé‚£è¾¹ä¼ æ¥äº²åˆ‡çš„é—®å€™ï¼šâ€œå®¶é•¿ä½ å¥½ï¼Œè¿™é‡Œæ˜¯æµ·æ·€åå¸ˆâ€¦â€¦â€ ä»–è¿˜æ²¡ç­‰æˆ‘å‘è¯ï¼Œâ€œå•ªâ€å°±ç»™æŒ‚äº†ï¼Œç„¶åè½¬è¿‡å¤´ï¼Œç”¨ä¸€ç§æ•…ä½œå¹³é™çš„å¾®å¦™è¯­æ°”è®²ï¼šâ€œåƒåœ¾ç”µè¯ï¼Œä¸ç”¨ç†ã€‚â€  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tAilFuv">é™¶é™¶å±… - è½¬å‘ @æ°´ç­ä¸€èˆ¬ç¼–-é˜¿æ€¡:&amp;ensp;å¹¿å·è€å¹¿ä»¬æ¨èä¸ªè‡ªå·±è§‰å¾—å¯ä»¥çš„æ—©èŒ¶å‘—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tailfuv/">
    
    
    
    
    
      
    
    é™¶é™¶å±…<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ°´ç­ä¸€èˆ¬ç¼–-é˜¿æ€¡<!-- raw HTML omitted -->:â€‚å¹¿å·è€å¹¿ä»¬æ¨èä¸ªè‡ªå·±è§‰å¾—å¯ä»¥çš„æ—©èŒ¶å‘— &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tCiaqPY">ğŸ”»æˆ‘ä»¬ç°åœ¨éƒ½æ˜¯ç”¨ä¸‰å°æ—¶å¯¹æ¥æ–¹æ¡ˆäº†ï¼ŒçœŸå¿«å•Šã€‚ğŸ”»å›¾4 via @Seger_YU #å¤©èˆŸå…«å·å‘å°„# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tciaqpy/">
    
    
    
    
    
      
    
    ğŸ”»æˆ‘ä»¬ç°åœ¨éƒ½æ˜¯ç”¨ä¸‰å°æ—¶å¯¹æ¥æ–¹æ¡ˆäº†ï¼ŒçœŸå¿«å•Šã€‚<!-- raw HTML omitted -->ğŸ”»å›¾4 via <!-- raw HTML omitted -->@Seger_YU<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å¤©èˆŸå…«å·å‘å°„#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hvneri51btj20zk0k0jrl.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1hvneri51btj20zk0k0jrl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tFhadPu">ä¸¢[å“†å•¦Aæ¢¦å®³æ€•]//@å¾å®¶ç‹¬å­:æ…å…¥ è¯„è®ºé…å›¾ //@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:é™¶é™¶å±… - è½¬å‘ @æ°´ç­ä¸€èˆ¬ç¼–-é˜¿æ€¡:&amp;ensp;å¹¿å·è€å¹¿ä»¬æ¨èä¸ªè‡ªå·±è§‰å¾—å¯ä»¥çš„æ—©èŒ¶å‘—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tfhadpu/">
    
    
    
    
    
      
    
    ä¸¢<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å¾å®¶ç‹¬å­<!-- raw HTML omitted -->:æ…å…¥ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png%22">https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png&quot;</a> referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tg6cSZi">ğŸ”»æˆ‘èŠ±äº†å¥½å‡ ç§’é’Ÿæ‰è®¤å‡ºè§†é¢‘1è¿™å¯æ€•çš„æ°´ä¸‹ç”Ÿç‰©æ˜¯ä»€ä¹ˆâ€¦â€¦ğŸ”»via Nature is Amazing [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tg6cszi/">
    
    
    
    
    
      
    
    ğŸ”»æˆ‘èŠ±äº†å¥½å‡ ç§’é’Ÿæ‰è®¤å‡ºè§†é¢‘1è¿™å¯æ€•çš„æ°´ä¸‹ç”Ÿç‰©æ˜¯ä»€ä¹ˆâ€¦â€¦<!-- raw HTML omitted -->ğŸ”»via Nature is Amazing <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tiri2Rs">ğŸ”»ç½‘å‹åˆ†äº«ï¼Œä¸€ä¸ªæµ‹è¯•è§†é¢‘ã€‚ğŸ”»ä¿„ä¹Œå†²çªä¸­ï¼Œä¿„ä¹ŒåŒæ–¹éƒ½æ›¾å°è¯•è¿‡æ— äººæœºæ­è½½è½»æ­¦å™¨ï¼Œä½†æ˜¯æœ€ç»ˆå¹¶æ²¡æœ‰æ™®åŠã€‚ğŸ”»å¯èƒ½æ˜¯å› ä¸ºç‚¹æ€ä¼¤ä¸å¦‚é¢æ€ä¼¤æ¶ˆè´¹æ¯”é«˜ï¼Œå¹¶ä¸”æŠ€æœ¯æ‰€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tiri2rs/">
    
    
    
    
    
      
    
    ğŸ”»ç½‘å‹åˆ†äº«ï¼Œä¸€ä¸ªæµ‹è¯•è§†é¢‘ã€‚<!-- raw HTML omitted -->ğŸ”»ä¿„ä¹Œå†²çªä¸­ï¼Œä¿„ä¹ŒåŒæ–¹éƒ½æ›¾å°è¯•è¿‡æ— äººæœºæ­è½½è½»æ­¦å™¨ï¼Œä½†æ˜¯æœ€ç»ˆå¹¶æ²¡æœ‰æ™®åŠã€‚<!-- raw HTML omitted -->ğŸ”»å¯èƒ½æ˜¯å› ä¸ºç‚¹æ€ä¼¤ä¸å¦‚é¢æ€ä¼¤æ¶ˆè´¹æ¯”é«˜ï¼Œå¹¶ä¸”æŠ€æœ¯æ‰€é™ï¼Œåœ¨ç²¾å‡†å°„å‡»å’Œæ•ˆè´¹æ¯”ä¹‹é—´å¾ˆéš¾æ‰¾åˆ°å¹³è¡¡ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax1.sinaimg.c">https://tvax1.sinaimg.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tm3fVQw">ä¸€ä¸ªè¯ç‚¹é¢˜ï¼šâ€œé‡Šç»æƒâ€ã€‚â€œæ²¡æœ‰ç»è¿‡å°åœˆå­ç‚¹å¤´è®¤å¯è½¬å‘å¹æ§ï¼Œæ²¡æœ‰ç»™å°åœˆå­é‡Œçš„è€å‰è¾ˆä»¬å¥‰èŒ¶ä¸Šä¾›ï¼Œä½ æ€ä¹ˆå¥½æ„æ€å¸¦ç€è¿™ä¹ˆå·¨å¤§çš„æµé‡æ€è¿›æˆ‘ä»¬çš„èµ›é“é‡Œæ¥å‘¢ï¼Ÿâ€//@2...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tm3fvqw/">
    
    
    
    
    
      
    
    ä¸€ä¸ªè¯ç‚¹é¢˜ï¼šâ€œé‡Šç»æƒâ€ã€‚â€œæ²¡æœ‰ç»è¿‡å°åœˆå­ç‚¹å¤´è®¤å¯è½¬å‘å¹æ§ï¼Œæ²¡æœ‰ç»™å°åœˆå­é‡Œçš„è€å‰è¾ˆä»¬å¥‰èŒ¶ä¸Šä¾›ï¼Œä½ æ€ä¹ˆå¥½æ„æ€å¸¦ç€è¿™ä¹ˆå·¨å¤§çš„æµé‡æ€è¿›æˆ‘ä»¬çš„èµ›é“é‡Œæ¥å‘¢ï¼Ÿâ€//<!-- raw HTML omitted -->@2ç‚¹5æ¬¡å…ƒçš„è€ç ´<!-- raw HTML omitted -->:æœ€è®©æˆ‘æ— è¯­çš„æ˜¯é¦–é¡µä¸€äº›çœ‹èµ·æ¥å²æœˆé™å¥½é’»ç ”ä¼ ç»Ÿæ–‡åŒ–çš„è¿™ç§æ—¶å€™çªç„¶è·³å‡ºæ¥è¯´äº›æ€ªè¯â€¦ä»€ä¹ˆçœŸçš„ä¸“å¿ƒä¼ æ‰¿çš„æ‰‹è‰ºäººæ²¡äººçœ‹å•¦æ¼‚äº®å°å§‘å¨˜æç‚¹æ»¤é•œå°±ä¸€å †äººè¿½æ§å•¦â€¦ä»€ä¹ˆä½ ä»¬ä¸æ˜¯å–œæ¬¢å†œæ‘æ°›å›´å’Œä¼ ç»Ÿæ–‡åŒ–ä½ ä»¬å°±æ˜¯å–œæ¬¢å¥¹ç«å•¦â€¦â€¦ä¸ç®¡å‡ºå‘ç‚¹æ˜¯ä»€ä¹ˆï¼Œè¿™ç§åšæ´¾çœŸçš„è¿˜æŒºè®©äººä¸é€‚çš„<!-- raw HTML omitted -->&lt;img alt=&quot;[ç”Ÿç—…]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_shengbing-b740fa9852.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_shengbing-b740fa9852.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tmMA9uM">ğŸ”»æœ‰äººè¯´å¼ ç‰å®è¿›ä¸–ç•Œæ¯çš„å‡ ç‡ç°åœ¨æ¯”å“ˆå…°å¾·å¤§ã€‚ğŸ”»â€¦â€¦åˆ«å¥¶ã€‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tmma9um/">
    
    
    
    
    
      
    
    ğŸ”»æœ‰äººè¯´å¼ ç‰å®è¿›ä¸–ç•Œæ¯çš„å‡ ç‡ç°åœ¨æ¯”å“ˆå…°å¾·å¤§ã€‚<!-- raw HTML omitted -->ğŸ”»â€¦â€¦åˆ«å¥¶ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0to44wcE">ğŸ”»ä»”ç»†æƒ³æƒ³ï¼Œç¾å›½å€™ä»»æ€»ç»Ÿç¬¬ä¸€æ—¶é—´èƒ½æ‰¾åˆ°æ¥æµ·æ¹–åº„å›­ä¸€èµ·ç«™å°çš„ï¼Œå±…ç„¶æ˜¯é˜¿æ ¹å»·ã€‚ğŸ”»è¿™å¯æ¯”ä¸Šä¸€ä¸ªä»»æœŸçš„shinzoå·®è¿œäº†ã€‚ğŸ”»çœŸæ˜¯ä¸€å±Šä¸å¦‚ä¸€å±Šã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0to44wce/">
    
    
    
    
    
      
    
    ğŸ”»ä»”ç»†æƒ³æƒ³ï¼Œç¾å›½å€™ä»»æ€»ç»Ÿç¬¬ä¸€æ—¶é—´èƒ½æ‰¾åˆ°æ¥æµ·æ¹–åº„å›­ä¸€èµ·ç«™å°çš„ï¼Œå±…ç„¶æ˜¯é˜¿æ ¹å»·ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™å¯æ¯”ä¸Šä¸€ä¸ªä»»æœŸçš„shinzoå·®è¿œäº†ã€‚<!-- raw HTML omitted -->ğŸ”»çœŸæ˜¯ä¸€å±Šä¸å¦‚ä¸€å±Šã€‚ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tqg3qKi">6 - è½¬å‘ @å¤§å¤§å¤§é¤…å¹²ä¸¶:&amp;ensp;å°æ¹¾å¾ˆå¤šå·¥å‚éƒ½æ²¡æœ‰è®¢å•äº†...ä»¥å‰ç»™å°æ¹¾çš„è®¢å•å¤ªå¤šï¼Œè®©ç»¿è‰²èµšå¤šäº†ä¼šæå°ç‹¬ï¼Œç°åœ¨å¤§é™†ç»™çš„è®¢å•ä¹Ÿå°‘äº†ï½å°æ¹¾ç½‘å‹è¯´ä»–ä»¬å·¥å‚å¾€å¹´å¹´åº•...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tqg3qki/">
    
    
    
    
    
      
    
    6<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤§å¤§å¤§é¤…å¹²ä¸¶<!-- raw HTML omitted -->:â€‚å°æ¹¾å¾ˆå¤šå·¥å‚éƒ½æ²¡æœ‰è®¢å•äº†&hellip;<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»¥å‰ç»™å°æ¹¾çš„è®¢å•å¤ªå¤šï¼Œè®©ç»¿è‰²èµšå¤šäº†ä¼šæå°ç‹¬ï¼Œç°åœ¨å¤§é™†ç»™çš„è®¢å•ä¹Ÿå°‘äº†ï½<!-- raw HTML omitted --><!-- raw HTML omitted -->å°æ¹¾ç½‘å‹è¯´ä»–ä»¬å·¥å‚å¾€å¹´å¹´åº•æ—¶å€™å¾ˆå¿™ï¼Œä½†ä»Šå¹´èµ–æ¸…å¾·ä¸Šå°åé—²å¾—å‘æ…Œï¼Œè€Œå›æƒ³èµ·é©¬è‹±ä¹æ—¶ä»£ï¼Œå¤§å®¶éƒ½èµšç¿»äº†ï½<!-- raw HTML omitted --><!-- raw HTML omitted -->é¢„æµ‹å†è¿‡å‡ å¹´å°æ¹¾å¾ˆå¤šå·¥å‚å¯èƒ½è¦å€’é—­æˆ–è€…ç§»åˆ°å¤–å›½ï¼Œåˆ°æ—¶å€™å¤§é™†ä¸ç”¨æ‰“å°æ¹¾è‡ªå·±å°±æƒ³ç»Ÿä¸€&hellip;<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaim">https://tvax2.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tz7ALTA">ä½ è¿™æ˜¯ä»€ä¹ˆå²è§‚ï¼Ÿå…¶å®å°±æ˜¯å¼ºè°ƒæ¸…æœå¾æœå±æ€§çš„å²è§‚ï¼Œç›´æ¥å¦å®šäº†ä¸­å›½è¿‘ä»£ä»¥æ¥å½¢æˆçš„â€œå°‘æ•°æ°‘æ—å¿…å°†è¢«ä¸­åæ–‡æ˜åŒåŒ–â€çš„å†å²å™è¿°æ–¹å¼ã€‚è¿™å°±æ˜¯å°é¬¼å­çš„å†…äºšå²è§‚ï¼Œé€šè¿‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tz7alta/">
    
    
    
    
    
      
    
    ä½ è¿™æ˜¯ä»€ä¹ˆå²è§‚ï¼Ÿå…¶å®å°±æ˜¯å¼ºè°ƒæ¸…æœå¾æœå±æ€§çš„å²è§‚ï¼Œç›´æ¥å¦å®šäº†ä¸­å›½è¿‘ä»£ä»¥æ¥å½¢æˆçš„â€œå°‘æ•°æ°‘æ—å¿…å°†è¢«ä¸­åæ–‡æ˜åŒåŒ–â€çš„å†å²å™è¿°æ–¹å¼ã€‚è¿™å°±æ˜¯å°é¬¼å­çš„å†…äºšå²è§‚ï¼Œé€šè¿‡è¿™ç§ååŠ¨ç†è®ºï¼ŒæŠŠä¸­å›½å‡ åƒå¹´æ¥å„æ°‘æ—èåˆæ‰€å½¢æˆçš„æ°‘ç³»å…³ç³»å¼ºè¡Œå‰²è£‚ï¼ŒæŠŠç°ä»£ä¸­å›½å„æ°‘æ—æ‰€å»ºç«‹çš„å…±åŒå†å²æƒ³è±¡åŸºç¡€çš„åå¤ä¸­å¿ƒè®ºå»é™¤ï¼Œåˆ†åŒ–ç“¦è§£å¦å®šç°ä»£ä¸­å›½çš„ä¸€åˆ‡ã€‚æŠ±æ­‰ï¼Œè·Ÿæ—¥æœ¬å­¦å†å²çš„å¸å·åœ¨æˆ‘è¿™é‡Œæ²¡æœ‰ç«‹è¶³ä¹‹åœ°ã€‚//<!-- raw HTML omitted -->@å¤©æ—æ™šé’Ÿ<!-- raw HTML omitted -->:åŒ…åŒ…ï¼Œæ¨æ»¡æ–‡ï¼Œæ–­ä¸­åæ–‡è„‰ï¼Œä¸­å›½å‡ ä¹æˆäº†æ–‡ç›²å¤§å›½ï¼Œè¿™æ¯”ä¹±ç¼–æ˜å²ï¼Œå¦å®šå†å²æ›´å¤šã€‚ä¸èƒ½å› ä¸ºé˜¿å«²è¢«qjç”Ÿå­ï¼Œæ‰€ä»¥åä»£å°±åº”è¯¥æ„Ÿè°¢é‚£ä¸ªqjçŠ¯å§ï¼Œå“ªæ€•qjçŠ¯æŠŠè¿™ä¸ªåŸæœ¬å¯Œè£•çš„å®¶æŠ˜è…¾å¾—ä¸€è´«å¦‚æ´—ï¼Œè™å¾…é…·åˆ‘æŠ˜ç£¨å®¶åº­æˆå‘˜ï¼Œå¯ä»–æ¯•ç«Ÿæ˜¯çˆ¶äº²å•Šï¼è¿™ç§è‡ªè™å²è§‚æ•æˆ‘æ¥å—ä¸èƒ½ã€‚<!-- raw HTML omitted -->&lt;img alt=&quot;[æŒ–é¼»]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_wabishi-816c">https://h5.sinaimg.cn/m/emoticon/icon/default/d_wabishi-816c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0nL3fTIB">ä¹…ä¿å²ç»ªé‡Œ ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ï¼ã€EP.22 é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0nl3ftib/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ï¼ã€EP.22 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0nNKtBco">ä¹…ä¿å²ç»ªé‡Œ ä¹ƒæœ¨å‚46 37th ã€Œæ­¥é“æ©‹ã€Type-D å°é¢ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0nnktbco/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ä¹ƒæœ¨å‚46 37th ã€Œæ­¥é“æ©‹ã€Type-D å°é¢ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0qE04aCp">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.11.15 18:10ã€Œå“Ÿã€ä»Šå¤©ä¹Ÿè¾›è‹¦äº†æ˜¨å¤©ä¹Ÿä¹…è¿åœ°ä¸€å›å®¶å°±ç¡ç€äº†ã€ã€ã€ã€è™½ç„¶ä¹Ÿæœ‰è¿™æ ·çš„æ—¥å­ï¼Œä½†ç²¾ç²¾ç¥ç¥åœ°å‡ºå‘å§ï¼ï¼ï¼ä»Šå¤©ä¹Ÿè¦...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0qe04acp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;is">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;is</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0tiho4v7">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¬¬å…­å‘¨ä¸€æ¬¡è¿‡é‡æ’­è°¢è°¢å•¦å¤ªæ£’äº†...é›†ä¸­ç²¾ç¥å®æ—¶çœ‹äº†ã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0tiho4v7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39539235/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">A Low-Cost Workflow to Generate Virtual and Physical Three-Dimensional Models of Cardiac Structures</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39539235-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Three-dimensional modeling and printing might improve planning and safety of congenital cardiac surgical treatment. Furthermore, it is a useful tool for education of parents and medical professionals. This workflow increases its suitability for routine use also in regions with low economic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39539954/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39539954-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: In recent years, high-density microelectrode arrays (HD-MEAs) have emerged as a valuable tool in preclinical research for characterizing the electrophysiology of human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs). HD-MEAs enable the capturing of both extracellular and intracellular signals on a large scale, while minimizing potential damage to the cell. However, despite technological advancements of HD-MEAs, there is a lack of effective data-analysis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540283/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Emerging Imaging Techniques for Atherosclerosis in Systemic Immune-Mediated Inflammatory Conditions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540283-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Atherosclerosis affects patients with systemic immune-mediated inflammatory diseases at an increased rate compared with the general population. In recent years, our understanding of the pathophysiology of atherosclerosis has advanced considerably. Nevertheless, cardiovascular imaging modalities that can adequately assess the biological background of atherosclerosis have not reached widespread clinical adoption. Novel developments in cardiac imaging have the potential to enhance the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540861/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Evaluating the Impact of Retinal Vessel Segmentation Metrics on Retest Reliability in a Clinical Setting: A Comparative Analysis Using AutoMorph</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540861-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings highlight a considerable volatility in the reliability of some retinal biomarkers. Improving retest could allow disease progression modeling in smaller datasets or an individualized treatment approach. Image quality is moderately predictive of retest reliability, and further work is warranted to understand the reasons behind our observations better and thus ensure consistent retest &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Psychological Women&#39;s Liberation: Feminist Therapy Between Psychology and the Women&#39;s Movement in the Federal Republic of Germany in the 1970s</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540917-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    From the late 1960s onwards, the early second women&rsquo;s movement encompassed all areas of West German society. This included debates about how women&rsquo;s healthcare could be improved in a self-determined, women-friendly way and in line with feminist ideals. These debates were also held with regard to the general boom in psychotherapy at the time. This article explores the question of how debates around feminist therapy emerged in the Federal Republic of Germany. It also looks at the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541094/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241114180133&amp;v=2.18.0.post9&#43;e462414">Inebilizumab for Treatment of IgG4-Related Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541094-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241114180133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Inebilizumab reduced the risk of flares of IgG4-related disease and increased the likelihood of flare-free complete remission at 1 year, confirming the role of CD19-targeted B-cell depletion as a potential treatment for IgG4-related disease. (Funded by Amgen; MITIGATE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541094/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Inebilizumab for Treatment of IgG4-Related Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541094-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241115181608-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Inebilizumab reduced the risk of flares of IgG4-related disease and increased the likelihood of flare-free complete remission at 1 year, confirming the role of CD19-targeted B-cell depletion as a potential treatment for IgG4-related disease. (Funded by Amgen; MITIGATE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Let&#39;s YAP about ITP</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541102-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Let&#39;s YAP about ITP</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541102-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541103/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Location, location, location: EMD in MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541103-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541103/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Location, location, location: EMD in MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541103-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541104/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Oxidative hemolysis due to phenazopyridine in the absence of G6PD deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541104-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541104/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Oxidative hemolysis due to phenazopyridine in the absence of G6PD deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541104-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541105/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Ruxolitinib REACHes FOR children with GVHD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541105-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541105/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Ruxolitinib REACHes FOR children with GVHD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541105-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541189/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241115181459&amp;v=2.18.0.post9&#43;e462414">SpaGIC: graph-informed clustering in spatial transcriptomics via self-supervised contrastive learning</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541189-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241115181459-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spatial transcriptomics technologies enable the generation of gene expression profiles while preserving spatial context, providing the potential for in-depth understanding of spatial-specific tissue heterogeneity. Leveraging gene and spatial data effectively is fundamental to accurately identifying spatial domains in spatial transcriptomics analysis. However, many existing methods have not yet fully exploited the local neighborhood details within spatial information. To address this issue, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541573/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Approaching a therapeutic inflection point for FLT3-mutated AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541573-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Combining FLT3 inhibitors with intensive chemotherapy and transplant has substantially improved AML outcomes, prompting a recent re-evaluation of FLT3-ITD&rsquo;s historically negative prognostic effect. Treatment approaches may soon undergo major changes as emerging data suggest maximal intensity does not benefit all patients and MRD potentially can guide several treatment choices. Finally, recent data also suggest FLT3 inhibitors could transform outcomes in patients unsuitable for intensive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541574/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541574-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Arterial and venous thromboses are the most significant complications in patients with myeloproliferative neoplasms (MPN), with the primary treatment goal being thrombotic risk reduction. In MPN with no history of thrombosis, primary prevention mainly involves the use of aspirin and cytoreduction is added in high-risk patients. However, thrombotic complications can unveil an MPN in approximately 20% of cases, necessitating the initiation of both antithrombotic therapy for the thrombosis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541576/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Imetelstat: A new addition to the Therapeutic Landscape of Lower-Risk MDS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541576-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Anemia is the most prevalent cytopenia in lower-risk myelodysplastic neoplasms (LR-MDS). There is a paucity of drugs for red blood cell transfusion dependence (RBC-TD) and erythropoiesis-stimulating agents (ESAs) are the mainstay of therapy in many centers. Imetelstat, an oligonucleotide telomerase inhibitor, was recently approved for RBC-TD LR-MDS adults who are ineligible or failed prior ESA therapy. While not yet approved worldwide, here, we spotlight the current data for imetelstat and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541577/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541577-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541586/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Ferroptosis regulates hemolysis in stored murine and human red blood cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541586-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Red blood cell (RBC) metabolism regulates hemolysis during aging in vivo and in the blood bank. However, the genetic underpinnings of RBC metabolic heterogeneity and extravascular hemolysis at population scale are incompletely understood. Based on the breeding of 8 founder strains with extreme genetic diversity, the Jackson laboratory diversity outbred population can capture the impact of genetic heterogeneity in like fashion to population-based studies. RBCs from 350 outbred mice, either &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39542070/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241115181459&amp;v=2.18.0.post9&#43;e462414">SpaInGNN: Enhanced clustering and integration of spatial transcriptomics based on refined graph neural networks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39542070-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241115181459-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent developments in spatial transcriptomics (ST) technology have markedly enhanced the proposed capacity to comprehensively characterize gene expression patterns within tissue microenvironments while crucially preserving spatial context. However, the identification of spatial domains at the single-cell level remains a significant challenge in elucidating biological processes. To address this, SpaInGNN was developed, a sophisticated graph neural network (GNN) framework that &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0dVif7KL">æ˜¨å¤©çœ‹åˆ°TrumpæåPete Hegsethä»»å›½é˜²éƒ¨éƒ¨é•¿ï¼Œæˆ‘å½“æ—¶ç¬¬ä¸€ååº”æ˜¯F**Kï¼Œä»Šå¤©çœ‹åˆ°ä»–æåMatt Gaetzå½“AGï¼Œæˆ‘è§‰å¾—ï¼Œå¥½å§ï¼Œä»–å…¶å®ä¹Ÿæ²¡æƒ³å®ç°ä»–è¯´çš„é‚£äº›â€œè®¡åˆ’â€ã€‚å¦‚æœ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0dvif7kl/">
    
    
    
    
    
      
    
    æ˜¨å¤©çœ‹åˆ°TrumpæåPete Hegsethä»»å›½é˜²éƒ¨éƒ¨é•¿ï¼Œæˆ‘å½“æ—¶ç¬¬ä¸€ååº”æ˜¯F**Kï¼Œä»Šå¤©çœ‹åˆ°ä»–æåMatt Gaetzå½“AGï¼Œæˆ‘è§‰å¾—ï¼Œå¥½å§ï¼Œä»–å…¶å®ä¹Ÿæ²¡æƒ³å®ç°ä»–è¯´çš„é‚£äº›â€œè®¡åˆ’â€ã€‚å¦‚æœä»–çœŸæƒ³å…‘ç°ä»–è¯´çš„å»é•‡å‹åå¯¹è€…ï¼Œä»–ä¸ä¼šé€‰Matt Gaetzã€‚è¿™è®©æˆ‘æƒ³èµ·äº†Succession S4E2 Logan Royé‚£å¥ç»å…¸åè¨€ï¼šYou are not serious peopleï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->æœ‰è¶£çš„æ˜¯ï¼Œä»Šå¤©å‚è®®é™¢GOPæ²¡æœ‰é€‰ä»–çš„å¿ å®éšä»Rick Scottï¼Œè€Œæ˜¯é€‰äº†å»ºåˆ¶æ´¾John Thuneå½“Majority Leaderï¼ˆå¤šæ•°æ´¾é¢†è¢–ï¼‰ï¼Œè¿™å®é™…ä¸Šæ˜¯Mitch McConnellé¦–é€‰çš„ï¼Œè¿™å…¶å®å’Œå†æ¬¡ä¸€æ ·ï¼Œå¤§é€‰å‰å›¢ç»“ï¼Œå¤§é€‰åç«‹åˆ»å„è‡ªä¸ºæ”¿ï¼Œè¿™ä¸€ç»“æœè®©ä»Šåçš„å†…é˜ä»»å‘½å°†å˜å¾—è‰°éš¾ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0f8v5XU0">æ™šä¸Šåˆ°Genentechï¼ˆåŸºå› æ³°å…‹ï¼‰å‚åŠ æ´»åŠ¨ã€‚Genentechæ˜¯å…¨ä¸–ç•Œç¬¬ä¸€ä¸ªbiotechï¼ˆç”Ÿç‰©æŠ€æœ¯ï¼‰å…¬å¸ï¼Œä¹Ÿæ˜¯æ¹¾åŒºæœ€å¤§biopharmaï¼ˆç”Ÿç‰©åˆ¶è¯ï¼‰å…¬å¸ã€‚ä»Šå¤©è®¤è¯†äº†é™„è¿‘å…¬å¸çš„åŒè¡Œï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0f8v5xu0/">
    
    
    
    
    
      
    
    æ™šä¸Šåˆ°Genentechï¼ˆåŸºå› æ³°å…‹ï¼‰å‚åŠ æ´»åŠ¨ã€‚Genentechæ˜¯å…¨ä¸–ç•Œç¬¬ä¸€ä¸ªbiotechï¼ˆç”Ÿç‰©æŠ€æœ¯ï¼‰å…¬å¸ï¼Œä¹Ÿæ˜¯æ¹¾åŒºæœ€å¤§biopharmaï¼ˆç”Ÿç‰©åˆ¶è¯ï¼‰å…¬å¸ã€‚ä»Šå¤©è®¤è¯†äº†é™„è¿‘å…¬å¸çš„åŒè¡Œï¼ŒåŒ…æ‹¬Genentechå’ŒBioMarinç§‘å­¦å®¶ï¼ŒUCSFå’ŒKaiserçš„åŒ»ç”Ÿï¼Œå®‰æ°¸çš„æŠ•èµ„äººï¼Œè¿˜æœ‰å„ç§åˆ›ä¸šè€…ã€‚è®¨è®ºæœ€å¤šçš„ä¸¤ä¸ªè¯ï¼šADCå’ŒAIã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å›½Â·South San Francisco<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/4a994b1dgy">https://tvax4.sinaimg.cn/large/4a994b1dgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0m8DlrQm">RFK Jrè¢«æåä¸ºç¾å›½å«ç”Ÿéƒ¨éƒ¨é•¿äº†ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ã€‚æ­£åœ¨åƒé¥­æ—¶ï¼Œåœ¨DCçš„æœ‹å‹ç»™æˆ‘å‘çŸ­ä¿¡å‘Šè¯‰æˆ‘è¿™ä¸ªæ¶ˆæ¯ï¼Œæˆ‘è¿˜ä»¥ä¸ºæ˜¯ä¸ªç¬‘è¯ï¼ˆparodyï¼‰ï¼Œæ²¡æƒ³åˆ°æ˜¯çœŸçš„ã€‚æˆ‘è§‰å¾—å³ä½¿GOP se...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0m8dlrqm/">
    
    
    
    
    
      
    
    RFK Jrè¢«æåä¸ºç¾å›½å«ç”Ÿéƒ¨éƒ¨é•¿äº†ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ã€‚æ­£åœ¨åƒé¥­æ—¶ï¼Œåœ¨DCçš„æœ‹å‹ç»™æˆ‘å‘çŸ­ä¿¡å‘Šè¯‰æˆ‘è¿™ä¸ªæ¶ˆæ¯ï¼Œæˆ‘è¿˜ä»¥ä¸ºæ˜¯ä¸ªç¬‘è¯ï¼ˆparodyï¼‰ï¼Œæ²¡æƒ³åˆ°æ˜¯çœŸçš„ã€‚æˆ‘è§‰å¾—å³ä½¿GOP senatorsä¹Ÿä¸ä¼šä»»å‘½ä»–çš„ã€‚ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0gIqCEVP">ä¹…ä¿å²ç»ªé‡Œ via.å‚äº•çœŸçºªå®˜æ¨ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0giqcevp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.å‚äº•çœŸçºªå®˜æ¨ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0gNOgzf3">ä¹…ä¿å²ç»ªé‡Œ ã€èª°ã‚ˆã‚Šã‚‚ã¤ã‚ˆãæŠ±ãã—ã‚ã¦ï¼ˆç´§ç´§æ‹¥æŠ±ï¼‰ã€å‰§ç…§ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0gnogzf3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ã€èª°ã‚ˆã‚Šã‚‚ã¤ã‚ˆãæŠ±ãã—ã‚ã¦ï¼ˆç´§ç´§æ‹¥æŠ±ï¼‰ã€å‰§ç…§ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/0">https://tvax4.sinaimg.cn/large/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jOmootf">ä¹…ä¿å²ç»ªé‡Œ è¢«æœªæ¥çš„æˆ‘æš´å‡» å‰§ç…§ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jomootf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> è¢«æœªæ¥çš„æˆ‘æš´å‡» å‰§ç…§ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hvm7gh1mbej31hc0">https://tvax4.sinaimg.cn/large/006z6nxLgy1hvm7gh1mbej31hc0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jQExknG">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# éå¸¸æ£’çš„ç…§ç‰‡ã€‚ã€‚â˜ºï¸ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jqexkng/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->éå¸¸æ£’çš„ç…§ç‰‡ã€‚ã€‚â˜ºï¸ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jQuBaWS">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä»Šæ™š10:45ï½ï¼ˆJSTï¼‰è¢«æœªæ¥çš„æˆ‘æš´å‡»ï¼ï¼Ÿæš´å‡»ç¬¬å…­å‘¨åœ¨ä»Šå¤©ä¹Ÿåˆ°æœ€åäº†ã€‚æ˜¨å¤©æ˜¯éå¸¸æ¸©æš–çš„ä¸€é›†å‘¢ã€‚ä»Šæ™šä¼šæ€ä¹ˆæ ·å‘¢ã€‚ã€‚åªå‰©ä¸‹ä¸¤å‘¨äº†ï¼Œè¯·ä¸€å®š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jqubaws/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jRccrFo">ä¹…ä¿å²ç»ªé‡Œ via.nhk_dramas [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jrccrfo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvm7oj88jcj30qo">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvm7oj88jcj30qo</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/11/14/1212866785/throughline-behind-the-scenes">Behind the Scenes of Throughline</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-11-14-1212866785-throughline-behind-the-scenes/">
    
    
    
    
    
      
    
    Today on the show, we&rsquo;re taking you behind the scenes. We&rsquo;ll tell you how Throughline was born, some of what goes into making our episodes, and a little bit about how we make our special sauce â€” the Throughline <!-- raw HTML omitted -->rizz, <!-- raw HTML omitted -->as the kids say.<!-- raw HTML omitted --><!-- raw HTML omitted -->If you want more of these behind-the-scenes conversations become a Throughline+ subscriber. You can find out more at plus.npr.org/throughline.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices.com/adchoices<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

